This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, H. F.
Right arrow Articles by Gentsch, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, H. F.
Right arrow Articles by Gentsch, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2004, p. 1434-1438, Vol. 42, No. 4
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.4.1434-1438.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Assessment of the Epidemic Potential of a New Strain of Rotavirus Associated with the Novel G9 Serotype Which Caused an Outbreak in the United States for the First Time in the 1995-1996 Season

H. Fred Clark,1* Diane A. Lawley,1 Alyssa Schaffer,1 Janice M. Patacsil,1 Amy E. Marcello,1 Roger I. Glass,2 Vivek Jain,2 and Jon Gentsch2

Division of AIID, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania,1 Viral Gastroenteritis Section, Centers for Disease Control and Prevention, Atlanta, Georgia2

Received 28 April 2003/ Returned for modification 14 July 2003/ Accepted 30 December 2003

Rotavirus causes severe morbidity in developed countries and frequent deaths (>=500,000 per year) in less-developed countries. Historically, four serotypes—G1, G2, G3, and G4—have predominated; they are distinguished by one of two surface neutralization antigens (VP7). However, in 1983 and 1984 we described a new rotavirus serotype, designated G9, in five children hospitalized for diarrhea in Philadelphia, Pa. G9 rotavirus was not identified again in the Western Hemisphere until it caused ca. 50% of the rotavirus disease detected in Philadelphia in the 1995-1996 season. This outbreak allowed us to question whether a rotavirus strain completely new to a well-studied community would target either very young infants or older children, cause especially severe disease, or completely displace previously extant serotypes. We observed a significant excess of G9 infections in younger infants (especially in those <6 months old) that might be attributed to the lack of G9-specific antibodies in mothers. Of further note, six of the seven oldest patients with rotavirus diarrhea were infected with the G9 strains (not significant). However, the age distribution of children with rotavirus did not differ over a 5-year study period regardless of the infecting serotype. Patients with diarrhea associated with G9 strains did not have disease more severe than that caused by the G1, G2, or G3 serotype. G9 strains did not displace the other serotypes but were virtually completely replaced by G1 or G2 serotypes in the three subsequent rotavirus seasons. We conclude that the abrupt appearance of this novel rotavirus serotype did not present a special threat to public health in the community.


* Corresponding author. Mailing address: Children's Hospital of Philadelphia, Division of Infectious Diseases, 3516 Civic Center Blvd., Philadelphia, PA 19104. Phone: (215) 590-2044. Fax: (215) 590-2025. E-mail: clarkf{at}email.chop.edu.


Journal of Clinical Microbiology, April 2004, p. 1434-1438, Vol. 42, No. 4
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.4.1434-1438.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Clark, H F., Lawley, D., Mallette, L. A., DiNubile, M. J., Hodinka, R. L. (2009). Decline in Cases of Rotavirus Gastroenteritis Presenting to The Children's Hospital of Philadelphia after Introduction of a Pentavalent Rotavirus Vaccine. CVI 16: 382-386 [Abstract] [Full Text]  
  • Tcheremenskaia, O., Marucci, G., De Petris, S., Ruggeri, F. M., Dovecar, D., Sternak, S. L., Matyasova, I., Dhimolea, M. K., Mladenova, Z., Fiore, L., and the Rotavirus Study Group, (2007). Molecular Epidemiology of Rotavirus in Central and Southeastern Europe. J. Clin. Microbiol. 45: 2197-2204 [Abstract] [Full Text]  
  • Lin, Y.-P., Chang, S.-Y., Kao, C.-L., Huang, L.-M., Chung, M.-Y., Yang, J.-Y., Chen, H.-Y., Taniguchi, K., Tsai, K.-S., Lee, C.-N. (2006). Molecular Epidemiology of G9 Rotaviruses in Taiwan between 2000 and 2002.. J. Clin. Microbiol. 44: 3686-3694 [Abstract] [Full Text]  
  • Rubilar-Abreu, E., Hedlund, K.-O., Svensson, L., Mittelholzer, C. (2005). Serotype G9 Rotavirus Infections in Adults in Sweden. J. Clin. Microbiol. 43: 1374-1376 [Abstract] [Full Text]